InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
0.8400
-0.0400 (-4.55%)
At close: Feb 4, 2026, 4:00 PM EST
0.8400
0.00 (0.00%)
Pre-market: Feb 5, 2026, 8:05 AM EST
InflaRx Market Cap
InflaRx has a market cap or net worth of $56.91 million as of February 5, 2026. Its market cap has decreased by -61.96% in one year.
Market Cap
56.91M
Enterprise Value
5.98M
1-Year Change
-61.96%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $56.91M, a decrease of -83.78%. That is a compound annual growth rate of -19.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 59.60M | -12.87% |
| Dec 31, 2025 | 68.40M | -52.96% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
| Nov 8, 2017 | 350.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeyondSpring | 62.09M |
| Alterity Therapeutics | 61.06M |
| NRx Pharmaceuticals | 60.39M |
| PMV Pharmaceuticals | 57.47M |
| Grace Therapeutics | 57.41M |
| Radiopharm Theranostics | 57.21M |
| Tevogen Bio Holdings | 56.57M |
| TScan Therapeutics | 56.51M |